Read more

April 21, 2020
1 min read
Save

AACR announces president-elect

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

David A. Tuveson, MD, PhD, FAACR
David A. Tuveson

David A. Tuveson, MD, PhD, FAACR, has been chosen president-elect of American Association for Cancer Research for 2020-2021.

He will begin his term April 29, and he will assume the AACR presidency in April 2021.

Tuveson is director of Cold Spring Harbor Laboratory Cancer Center, where he also serves as Roy J. Zuckerberg professor of cancer research. In addition, he is chief scientist for Lustgarten Foundation, a nonprofit organization dedicated to advancing and funding pancreatic cancer research.

“I am humbly honored to serve our community as the president-elect of the AACR,” Tuveson said in a press release. “The AACR’s mission is to improve the lives of people worldwide through supporting cancer research and education, and with the AACR’s leadership, much exciting progress has been made over the last 50 years.

“Sadly, however, many patients still suffer and die of cancer, and additional scientific and logistical challenges need to be overcome in order to improve their outcomes,” he added. “To articulate and then tackle these new challenges, I look forward to working with trainees, researchers, physicians, educators, policymakers, patients and their advocates, funding agencies, and corporate colleagues. Collectively, we can solve the hardest problems and help the most [patients with cancer].”

Tuveson — whose basic and translational research focuses on improving the understanding of pancreatic cancer biology, as well as identifying new approaches for treatment and diagnosis — is a medical staff affiliate at Memorial Sloan Kettering Cancer Center and also works closely with the Cancer Institute at Northwell Health.

“Dr. Tuveson is a highly distinguished physician-scientist whose pioneering pancreatic cancer research has had an enormous impact on our basic understanding and treatment of this deadly disease,” Margaret Foti, PhD, MD (hc), CEO of AACR, said in the release. “His scientific and clinical expertise, together with his visionary leadership and dedication to conquering cancer in all its forms, will be invaluable to the AACR as our organization continues to work toward the goal of preventing and curing all cancers. We are delighted that he has been elected to serve as the AACR’s 2020-2021 president-elect and our 2021-2022 president.”